CONCORDBIOBSECONCORD BIOTECH LIMITEDHighNeutral
Announced Tue, 27 Oct, 2026 · 19:22 IST

Unaudited Q2 revenue rises 25 percent while profit stays nearly flat

Revenue Growth 20pctEbitda Margin CompressionExceptional ItemResults View source PDFExplain this filing

CONCORDBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Q2 FY27 consolidated revenue rose 25.1 percent to Rs 309.07 crore, but profit after tax was nearly flat at Rs 63.06 crore versus Rs 62.90 crore. First-half revenue rose 25.6 percent to Rs 566.56 crore and profit after tax rose 18.8 percent to Rs 127.27 crore. FY26 figures include a Rs 3.28 crore labour-code charge classified as exceptional. First-half operating cash flow was Rs 168.21 crore. The 1:1 bonus record date is November 4, 2026.

Likely market impact

Revenue and cash flow rose, but profit lagged and margins narrowed. The 1:1 bonus should not change value; the labour-code charge was non-recurring.